Tumor-Type Agnostic, Targeted Therapies: BRAF Inhibitors Join the Group

In the present review, we briefly discuss the breakthrough advances in precision medicine using a tumor-agnostic approach and focus on BRAF treatment modalities, the mechanisms of resistance and the diagnostic approach in cancers with BRAF mutations. Tumor-type agnostic drug therapies work across ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Vranic, Semir, Basu, Gargi D., Hall, David W., Gatalica, Zoran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Sciences and Arts of Bosnia and Herzegovina 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116180/
https://www.ncbi.nlm.nih.gov/pubmed/36799315
http://dx.doi.org/10.5644/ama2006-124.392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116180/
https://www.ncbi.nlm.nih.gov/pubmed/36799315
http://dx.doi.org/10.5644/ama2006-124.392

Ejemplares similares